Processa Pharmaceuticals, Inc. — Investor Relations & Filings
Processa Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for patients with unmet medical needs in life-threatening and chronic diseases. The company's primary area of development is oncology, where it aims to improve the safety and efficacy of existing chemotherapy drugs through its Next Generation Cancer (NGC) therapies. Its pipeline includes PCS6422 for metastatic colorectal and breast cancer, PCS499 for Ulcerative Necrobiosis Lipoidica, and PCS12852 for gastroparesis and gastrointestinal motility disorders. Processa utilizes a regulatory science approach to efficiently advance its drug candidates through the development and approval process, with the goal of improving patient survival and quality of life.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Director's Dealing 2025 | 2025-10-03 | English | |
| Director's Dealing 2025 | 2025-10-03 | English | |
| Director's Dealing 2025 | 2025-10-03 | English | |
| Director's Dealing 2025 | 2025-10-03 | English | |
| Director's Dealing 2025 | 2025-10-03 | English | |
| S-8 | 2025-09-22 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 12503676 | Director's Dealing 2025 | 2025-10-03 | English | ||
| 12503677 | Director's Dealing 2025 | 2025-10-03 | English | ||
| 12503678 | Director's Dealing 2025 | 2025-10-03 | English | ||
| 12503679 | Director's Dealing 2025 | 2025-10-03 | English | ||
| 12503681 | Director's Dealing 2025 | 2025-10-03 | English | ||
| 12503685 | S-8 | 2025-09-22 | English | ||
| 12503687 | Director's Dealing 2025 | 2025-09-18 | English | ||
| 12503688 | Director's Dealing 2025 | 2025-09-18 | English | ||
| 12503690 | Director's Dealing 2025 | 2025-09-18 | English | ||
| 12503694 | Director's Dealing 2025 | 2025-09-18 | English | ||
| 12503693 | Director's Dealing 2025 | 2025-09-18 | English | ||
| 12503695 | Director's Dealing 2025 | 2025-09-18 | English | ||
| 12503697 | Director's Dealing 2025 | 2025-09-18 | English | ||
| 12503698 | Director's Dealing 2025 | 2025-09-18 | English | ||
| 12503700 | Director's Dealing 2025 | 2025-09-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Processa Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35172/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35172 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35172 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35172 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35172}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Processa Pharmaceuticals, Inc. (id: 35172)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.